Jetstar to Charge for Overhead Cabin Bags From February 
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions 
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip 
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations 
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing 
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns 
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results 
CHICAGO, March 20, 2018 -- R1 RCM Inc. (“R1” or the “Company”) (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced it has received approval for its common shares to trade on the Nasdaq Global Market effective at market open on March 21, 2018.
R1 shares previously traded on the Nasdaq Capital Market. Requirements for the Nasdaq Global Market are more stringent than those for the Nasdaq Capital Market. Companies must satisfy certain financial, liquidity and corporate governance requirements to be approved for listing on the Nasdaq Global Market. The Company’s ticker, “RCM,” will remain unchanged.
“The transfer of our listing to the Nasdaq Global Market reflects the financial progress R1 has made over the past year,” said Joe Flanagan, president and CEO of R1. “We are pleased to be listed on the Nasdaq Global Market, which includes some of the world's most innovative companies.”
About R1 RCM
R1 is a leading provider of technology-enabled revenue cycle management services which transform a health system’s revenue cycle performance across settings of care. R1’s proven and scalable operating model, the R1 Performance Stack℠, seamlessly complements a healthcare organization’s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. To learn more visit: R1RCM.com
Contact:
R1 RCM Inc.
Investor Relations:
Atif Rahim
312-324-5476
Media Relations:
Natalie Joslin
678-585-1206
